Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback